1. Home
  2. ZVIA vs NYXH Comparison

ZVIA vs NYXH Comparison

Compare ZVIA & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZVIA
  • NYXH
  • Stock Information
  • Founded
  • ZVIA 2007
  • NYXH 2009
  • Country
  • ZVIA United States
  • NYXH Belgium
  • Employees
  • ZVIA N/A
  • NYXH N/A
  • Industry
  • ZVIA Beverages (Production/Distribution)
  • NYXH Medical/Dental Instruments
  • Sector
  • ZVIA Consumer Staples
  • NYXH Health Care
  • Exchange
  • ZVIA Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • ZVIA 193.4M
  • NYXH 231.0M
  • IPO Year
  • ZVIA 2021
  • NYXH 2021
  • Fundamental
  • Price
  • ZVIA $2.58
  • NYXH $5.86
  • Analyst Decision
  • ZVIA Buy
  • NYXH Strong Buy
  • Analyst Count
  • ZVIA 4
  • NYXH 3
  • Target Price
  • ZVIA $4.61
  • NYXH $15.00
  • AVG Volume (30 Days)
  • ZVIA 785.0K
  • NYXH 161.7K
  • Earning Date
  • ZVIA 11-05-2025
  • NYXH 11-05-2025
  • Dividend Yield
  • ZVIA N/A
  • NYXH N/A
  • EPS Growth
  • ZVIA N/A
  • NYXH N/A
  • EPS
  • ZVIA N/A
  • NYXH N/A
  • Revenue
  • ZVIA $158,371,000.00
  • NYXH $5,793,306.00
  • Revenue This Year
  • ZVIA $6.24
  • NYXH $144.57
  • Revenue Next Year
  • ZVIA $6.81
  • NYXH $244.36
  • P/E Ratio
  • ZVIA N/A
  • NYXH N/A
  • Revenue Growth
  • ZVIA N/A
  • NYXH 2.94
  • 52 Week Low
  • ZVIA $0.90
  • NYXH $5.55
  • 52 Week High
  • ZVIA $4.99
  • NYXH $11.87
  • Technical
  • Relative Strength Index (RSI)
  • ZVIA 34.24
  • NYXH 35.49
  • Support Level
  • ZVIA $2.62
  • NYXH $5.60
  • Resistance Level
  • ZVIA $2.80
  • NYXH $6.13
  • Average True Range (ATR)
  • ZVIA 0.15
  • NYXH 0.30
  • MACD
  • ZVIA -0.03
  • NYXH -0.03
  • Stochastic Oscillator
  • ZVIA 4.45
  • NYXH 20.40

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: